Everest Clinical Research (Arlington) Acquires August Research
November 7, 2023
Everest Clinical Research, a portfolio company of Arlington Capital Partners, has acquired European contract research organization August Research. The deal expands Everest's European footprint and clinical trial (CTS) and pharmacovigilance (PV) capabilities across 14 countries; August's founders will remain with the business. Financial terms were not disclosed.
- Targets
- August Research
- Platforms
- Everest Clinical Research
- Industry
- Healthcare Services
- Location
- Sofia City Province, Bulgaria
- Transaction Type
- Addon
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.